Independent External Review Protocols: State Insurance Commissioner Petitions, Binding Determinations, and Reviewer Timelines

Written by Dr. Evelyn Reed, LCSW-C  |  Fact-checked using official US federal sources  |  Updated October 2026

When an insurance company issues a final Adverse Benefit Determination upholding its refusal to cover psychotherapy or psychiatric treatment, policyholders often believe they have reached a hopeless dead end. Having exhausted internal appeals with an insurer whose medical directors seem predisposed to protect corporate profit margins, patients feel powerless. However, under Section 2719 of the Public Health Service Act, enacted as part of the Affordable Care Act and enforced by the Centers for Medicare & Medicaid Services (CMS) and the U.S. Department of Labor (DOL), policyholders possess a formidable statutory right: the right to an Independent External Review.

1. The Statutory Right to Independent Adjudication: Taking Claims Outside the Insurer

The establishment of a universal external review mandate represents one of the most significant consumer victories in American health policy. Prior to federal healthcare reform, commercial insurers held exclusive, unchallengeable authority over internal claims appeals. If a plan’s medical director asserted that a treatment was “not medically necessary,” the policyholder’s only recourse was protracted, expensive litigation in state or federal court.

Under 45 CFR § 147.136, all non-grandfathered group health plans and individual health insurance issuers must provide an effective external review process. An external review applies to any adverse benefit determination involving: (1) medical judgment, including medical necessity, appropriateness, healthcare setting, level of care, or effectiveness of a covered benefit; (2) determinations that a treatment is experimental or investigational; and (3) determinations involving mental health parity compliance under MHPAEA.

Crucially, the decision of the Independent Review Organization (IRO) is 100% legally binding on the insurance company. If the independent medical reviewer concludes that your psychotherapy or psychiatric treatment was medically necessary, the insurer is legally mandated under federal law to immediately authorize coverage or disburse claim reimbursement. The insurer cannot appeal, refuse payment, or subject the overturned claim to further utilization review. However, the decision is not binding on the consumer: if the IRO upholds the denial, the policyholder retains their statutory right to file a civil lawsuit under ERISA Section 502(a).

2. Dual External Review Pathways: State Insurance Commissioners vs. Federal HHS Process

The administrative pathway for petitioning for an external review depends entirely on the regulatory classification of your health insurance policy:

• The State-Administered External Review Process: If you are enrolled in a fully insured commercial group plan (purchased by an employer from a commercial insurer) or an individual Marketplace plan, your external review is administered directly by your state’s Department of Insurance or Insurance Commissioner (e.g., the California Department of Managed Health Care [DMHC], the New York Department of Financial Services [DFS], or the Texas Department of Insurance). State programs are modeled upon the National Association of Insurance Commissioners (NAIC) Uniform Health Carrier External Review Model Act, establishing rigorous standards for independent review organization certification, strict reviewer conflict-of-interest firewalls, and consumer advocacy support through state-funded Consumer Assistance Programs (CAPs).
• The Federal External Review Process (CMS / HHS Process): If you are enrolled in a self-funded (self-insured) employer plan governed by federal ERISA law, your plan is exempt from state insurance regulation under the ERISA preemption doctrine. Self-funded plans must participate either in the Federal External Review Process administered by CMS and the Department of Health and Human Services (frequently contracted through Maximus Federal Services) or an accredited independent review organization contracted by the plan that satisfies the strict independence and consumer-protection criteria established under 29 CFR § 2560.503-1 and 45 CFR § 147.136.

Under both pathways, the commercial insurer pays 100% of the cost of the external review; the patient cannot be charged for the independent medical evaluation. If the external review organization determines that the denied treatment satisfies recognized standards of psychiatric care, the insurer is compelled by federal law to disburse payment immediately.

4. Independent Review Organizations (IROs): How External Boards Adjudicate

An Independent Review Organization (IRO) is an accredited medical entity staffed by practicing clinical physicians, psychologists, and healthcare specialists who evaluate contested claims completely independent of insurance company control. Under federal and state accreditation rules (such as URAC accreditation):

• Conflict of Interest Prohibitions: The assigned IRO medical reviewer cannot have any personal, professional, or financial relationship with the claimant, the treating clinician, or the insurance company. Furthermore, the reviewer’s compensation cannot be tied in any way to whether they uphold or overturn the denial.
• Exact Specialty Matching: Federal rules mandate that external reviews involving behavioral healthcare must be evaluated by a healthcare professional who holds an active, unencumbered clinical license in the same or similar specialty as the service under dispute. If an insurer denied an adolescent’s psychotherapy for an eating disorder or complex trauma, the claim must be evaluated by a board-certified child and adolescent psychiatrist or a licensed clinical psychologist specializing in adolescent eating disorders—not a general medical reviewer.
• Comprehensive Record Review: The IRO evaluates the complete administrative record, including all treating provider chart notes, letters of medical necessity, standardized psychometric tests, and published medical literature submitted by the patient.

5. Clinical Standards of Review: How IROs Overrule Commercial Medical Directors

When an internal insurance medical director reviews an appeal, they evaluate the claim through the lens of corporate utilization criteria (such as proprietary software designed to manage costs). When an independent IRO reviewer evaluates a claim, they apply broad, objective Accepted Clinical Practice Standards. The table below details the profound differences between internal insurer criteria and external IRO standards:

6. The State Insurance Commissioner & IRO Inquiry Script: Verifying Eligibility

To determine the correct external review channel and verify that your denial qualifies for independent adjudication, contact your State Department of Insurance Consumer Assistance Program or the Federal External Review portal using the dialogue script below:

7. Statutory Deadlines: The Strict 4-Month Filing Window and 72-Hour Fast-Tracks

Filing an external review petition is governed by strict, non-negotiable federal deadlines:

8. Step-by-Step Independent External Review Submission Protocol

Follow this systematic 8-step protocol to petition for an Independent External Review and secure a legally binding claim overturn:

“Independent external reviews are the great equalizer in healthcare disputes. Insurers frequently maintain denials through internal reviews, knowing that the appeals are handled by employees. But at the external review stage, over 55% of behavioral health denials evaluated by accredited IROs are overturned in favor of the patient, because independent medical specialists evaluate clinical science, not corporate bottom lines.”
— Lead Medical Director & Board-Certified Reviewer, Independent Review Organization

9. Frequently Asked Questions Regarding Independent External Reviews

How much does an Independent External Review cost the patient?

Under federal law and the Affordable Care Act, the external review process is virtually free for consumers. In the Federal External Review Process and under most state-administered systems, patients pay zero fees. In the few states that assess a nominal filing fee (typically $25), the fee is waived for low-income households, and the fee is 100% refunded to the patient if the external review overturns the insurer’s denial.

Can an insurance company ignore or appeal an IRO decision?

No. Under federal statute (45 CFR § 147.136), the decision of an Independent Review Organization is final and legally binding on the insurance company. The plan must immediately authorize the coverage or issue reimbursement. The insurer holds zero legal standing to appeal the IRO determination.

Can billing or coding disputes go to an Independent External Review?

Generally, external reviews are restricted to denials involving medical judgment, medical necessity, appropriateness, healthcare setting, level of care, experimental/investigational treatments, or mental health parity compliance. Pure contractual eligibility disputes (such as whether an employee paid their monthly premium) are generally not eligible for external review and must be resolved through administrative grievances or court.

What happens if the IRO upholds the insurance company’s denial?

If the IRO confirms the insurer’s denial, you have exhausted all non-judicial administrative remedies. At that stage, your remaining legal recourse is to consult a licensed healthcare ERISA attorney to evaluate filing a civil lawsuit in United States District Court under ERISA Section 502(a)(1)(B) or state consumer protection statutes.

How does an Expedited External Review work in an emergency?

If your treating clinician certifies in writing that an ongoing course of behavioral healthcare is at risk, or that standard review timelines could jeopardize your life or psychological health, you may request an Expedited External Review concurrently with your internal appeal. The independent reviewer must issue a binding determination within 72 hours of receipt of the petition.

10. Official Federal Regulatory Sources